Silver modification of polyethylene terephthalate textiles for antimicrobial protection

ASAIO Journal

Volumn 43, Issue 5, 1997, Pages

  Tweden, Katherine S ^d   Cameron, J Douglas ^e   Razzouk, Anees J ^b   Bianco, Richard W ^a   Holmberg, William R ^e   Bricault, Raymond J ^c   Barry, John E ^c   Tobin, Eric ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SPIRE CORPORATION   (United States)

^d St Jude Medical Inc USA   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BIOMATERIALS; CARDIOVASCULAR SURGERY; CHEMICAL MODIFICATION; DRUG THERAPY; MEDICAL PROBLEMS; POLYETHYLENE TEREPHTHALATES; SILVER;

ANTIMICROBIAL PROTECTION; PROSTHETIC VALVE ENDOCARDITIS; SEWING CUFFS; SHEEP MITRAL VALVE;

HEART VALVE PROSTHESES;

POLYETHYLENE TEREPHTHALATE; SILVER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; BACTERIAL ENDOCARDITIS; BACTERIOSTASIS; CONFERENCE PAPER; CONTROLLED STUDY; HEART VALVE PROSTHESIS; NONHUMAN; SHEEP;

EID: 0031239393     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199709000-00026     Document Type: Conference Paper

References (27)

1. Lytle BW, Priest BP, Taylor PC, et al.: Surgery for acquired heart disease. Surgical treatment of prosthetic valve endocarditis. J Thorac Cardiovasc Surg 111: 198-210, 1996.
2. Cowgill LD, Addonizio VP, Hopeman AR, Harken AH: A practical approach to prosthetic valve endocarditis. Ann Thorac Surg 43: 450-457, 1987.
3. Edmunds LH: Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg 44: 430-445, 1987.
4. Pansini S, di Summa M, Patane F, Foresennati PG, Serra M, Del Ponte S: Risk of recurrence after reoperation for prosthetic valve endocarditis. J Heart Valve Dis 6: 84-87, 1997.
5. Perrelli G, Piolatto G: Tentative reference values for gold, silver and platinum: literature data analysis. Sci Total Environ 120: 93-96, 1992.
6. Fox CL, Modak SM: Mechanism of silver sulfadiazine action on burn wound infections. Antimicrob Agents Chemother 5: 582-588, 1974.
7. Jansen B, Rinck M, Wolbring P, Strohmeier A, Jahns T: In vitro evaluation of the antimicrobial efficacy and biocompatibility of a silver-coated central venous catheter. J Biomater Appl 9: 55-70, 1994.
8. Liedberg H, Lundeberg T: Assessment of silver-coated urinary catheter toxicity by cell culture. Urol Res 17: 359-360, 1989.
9. Gravens DL, Margraf HW, Butcher HR, Ballinger WF: The antibacterial effect of treating suture with silver. Surgery 73: 122-127, 1973.
10. Kaga M, Seale NS, Hanawa T, Ferracaone JL, Waite DE, Okabe T: Cytotoxicity of amalgams, alloys, and their elements and phases. Dent Mater 7: 68-72, 1991.
11. Kinney EV, Bandyk DF, Seabrook GA, Kelly HM, Towne JB: Antibiotic-bonded PTFE vascular grafts: the effect of silver antibiotic on bioactivity following implantation. J Surg Res 50: 430-435, 1991.
12. Cannas M, Tobin EJ, Sioshansi P, Masse A, Rizzo E: Bacterial colonization of silver modified pin surfaces for external fixation: in vitro preliminary observations. Fifth World Biomater Congress Trans, p. 163, 1996.
13. Zisman WA: Relation of the equilibrium contact angle to liquid and constitution. Adv Chem Ser 43: 1-51, 1970.
14. Kaelble DH: Dispersion-polar surface tension properties of organic solids. J Adhesion 2: 66-81, 1970.
15. Irwin ED, Clack R, Lang G, et al.: Long-term evaluation of prosthetic mitral valves in sheep. J Invest Surg 6: 133-141, 1993.
16. Wan AT, Conyers RAJ, Coombs CJ, Masterton JP: Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem 37: 1683-1687, 1991.
17. Riley DK, Classen DC, Stevens LE, Burke JP: A large randomized clinical trial of a silver-impregnated urinary catheter. Am J Med 98: 349-356, 1995.
18. Grier N: Silver and its compounds, in Block SS (ed), Disinfection, Sterilization and Preservation, Philadelphia, Lea & Febiger, 1977, pp. 395-407.
19. Petering HG: Pharmacology and toxicology of heavy metals: silver. Pharmacol Ther [A] 1: 127-130, 1976.
20. Bambauer R, Mestres P, Schiel R, Sioshansi P: New surface-treatment technologies for catheters used for extracorporeal detoxification methods. Dialysis Transplant 24: 228-237, 1995.
21. Williams RL, Doherty PJ, Vince DG, Grashoff GJ, Williams DF: The biocompatibility of silver. CRC 5: 221-243, 1989.
22. Kluge RM, Calia FM, McLaughlin JS, Hornick RB: Source of contamination in open heart surgery. JAMA 230: 1415-1418, 1974.
23. Trooskin SZ, Donetz AP, Harvey RA, Greco RS: Prevention of catheter sepsis by antibiotic bonding. Surgery 97: 547-551, 1985.
24. Farber BF, Wolff AC: The use of nonsteriodal antiinflammatory drugs to prevent adherence of S. epidermidis to medical polymers. J Infect Dis 166: 861-865, 1992.
25. López-López G, Pascual A, Martínez-Martínez L, Perea EJ: Effect of a siliconized latex urinary catheter on bacterial adherence and human neutrophil activity. Diagn Microbiol Infect Dis 14: 1-6, 1991.
26. Cox AJ, Millington RS, Huskins DWL, Sutton TM: Resistance of catheters coated with a modified hydrogel to encrustation during an in vitro test, Urol Res 17: 353-356, 1989.
27. Gristina AG: Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 237: 1588-1595, 1987.